Latest Insights & Research

Stay informed with the latest public health research, insights, and evidence-based analysis from our team of experts.

Tag: hiv

All Workforce News Health equity Commentary Research Policy Society Mental health
Global

The Long-Lasting Impact of Lenacapavir

The landscape of HIV prevention is on the brink of a revolutionary shift with the introduction of a new drug that offers long-lasting protection against the virus. Known as lenacapavir, this injectable drug has recently received approval from the United States Food and Drug Administration (FDA) and is now being endorsed by the World Health […]

Read more →
Global

The Promise of Long-Acting Injections for HIV Prevention

So, in light of last week’s bad HIV news, here’s some good stuff In a significant leap forward in the fight against HIV, scientists and health organizations globally are celebrating the introduction of a long-acting injection that promises to transform prevention strategies. This groundbreaking solution is anticipated to offer near-total protection against HIV, and its […]

Read more →
Policy

The Impact of HIV Funding Cuts: A Ticking Time Bomb

The fight against HIV/AIDS has encountered a serious challenge due to significant cuts in funding from major international donors, including the United States. These reductions have raised concerns worldwide, especially in countries that rely heavily on international aid to maintain their healthcare systems and ensure ongoing access to life-saving HIV treatment and prevention services. The […]

Read more →
Policy

Leaked HHS Budget Reveals Deep Cuts—Who Will Suffer Most?

The U.S. Department of Health and Human Services (HHS) recently faced scrutiny after the leak of an internal document detailing extensive budget cuts. This proposal raises critical concerns about the future of public health programs and services nationwide. Here’s a detailed breakdown of where the major cuts lie and the potential impacts these could have […]

Read more →

Get the public-health insights you need—
every Thursday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

🔒 No spam. 1-click opt-out. Privacy-first.